R&D

Dear Research Advocate, The first presidential debate gave us little to go on regarding research for health. Americans are dying to know more ’€“ many, quite literally dying ’€“ about what either presidential candidate would do to speed up medical progress in the face of Alzheimer’€™s disease, Parkinson’€™s disease, ALS and the host of other disabling and deadly health threats that breed suffering, compromise independence and drive spiraling health care costs. Add to that the pivotal role medical innovation plays in our economy, and Americans absolutely deserve to know whether candidates will champion or shortchange it. All of us must say to candidates: Tell us what you will do, share your...
Dear Research Advocate, What do sequencing and sequestration have in common, besides being mysterious words to most people? It’€™s pretty simple: We won’€™t have more of the former if the latter takes place. Why isn’€™t it a Sputnik moment to learn that there is more sequencing capacity at Beijing Genome Institute than we have total capacity in our country? And, to learn that the Chinese government is subsidizing the cost of sequencing so that it is fast becoming the go-to place for industry and academia worldwide? It’€™s time for advocates to talk this up so that policy makers will once again plus-up research as a U.S. priority. Jeffrey Zients, the Acting Director of the White House Office...

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter